Form 4 for NEO NEOGENOMICS INC
Accepted 2021-11-29 00:00:00 ET · period of report 2021-11-24 · accession 0001077183-21-000251 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-29 | 2021-11-24 | NEO | Bonello William | Pres, Informatics | S - Sale+OE | $37.13 | -25.0K | 15.5K | -62% | -$928.3K |
| D | 2021-11-29 | 2021-11-24 | NEO | Bonello William | Pres, Informatics | M - OptEx | $8.03 | +25.0K | 40.5K | +162% | +$200.7K |
| D | 2021-11-29 | 2021-11-24 | NEO | Bonello William | Pres, Informatics | M - OptEx | $0.00 | -25.0K | 45.4K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-24 | S | D | 25,000 | $37.13 | 15,473 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-24 | M | A | 25,000 | $8.03 | 40,473 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-11-24 | M | D | 25,000 | $0.00 | 45,370 | D | $8.03 · — to 2023-02-26 | 25,000 Common Stock | (F3) On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date. (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |